|
Volumn 9, Issue 2 SPEC. ISS., 2005, Pages 127-130
|
Opioids in chronic non-cancer pain, indications and controversies
|
Author keywords
Chronic pain; Complications; Indications; Non cancer pain; Opioid
|
Indexed keywords
ANALGESIC AGENT;
BUPRENORPHINE;
CYCLOOXYGENASE 2 INHIBITOR;
FENTANYL;
MORPHINE;
NONSTEROID ANTIINFLAMMATORY AGENT;
OPIATE;
PARACETAMOL;
ANXIETY;
BEHAVIOR;
CHRONIC PAIN;
CLINICAL TRIAL;
COGNITIVE DEFECT;
CONSTIPATION;
DISEASE SEVERITY;
DRUG INDICATION;
DRUG POTENCY;
DRUG TOLERANCE;
DRUG USE;
ENDOCRINE DISEASE;
FOLLOW UP;
HUMAN;
IMMUNOPATHOLOGY;
LONG TERM CARE;
MEDICAL PRACTICE;
NAUSEA;
NEUROPATHIC PAIN;
PAIN;
PATIENT COMPLIANCE;
PATIENT SELECTION;
PRACTICE GUIDELINE;
PREDICTION;
PRIORITY JOURNAL;
PUBLICATION;
QUALITY OF LIFE;
REVIEW;
RISK ASSESSMENT;
SEDATION;
SIDE EFFECT;
SLEEP DISORDER;
SOCIAL PSYCHOLOGY;
TREATMENT OUTCOME;
WITHDRAWAL SYNDROME;
XEROSTOMIA;
|
EID: 14644392876
PISSN: 10903801
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ejpain.2004.05.013 Document Type: Article |
Times cited : (78)
|
References (8)
|